TCTelmo Carvalho

Telmo Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Telmo Carvalho has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predictive factors of recurrent endovascular intervention for cephalic arch stenosis after percutaneous transluminal angioplasty

    by Marta Neves, Cristina Outerelo, Marta Pereira, Fernando Neves, Telmo Carvalho, Pedro Maia, Pedro Ponce


  • The Role of Doppler Ultrassonography in Significant and Borderline Stenosis Definition

    by Ana Castro, Carla Moreira, Paulo Almeida, Norton de Matos, Luís Loureiro, Gabriela Teixeira, Duarte Rego, Sérgio Teixeira, Joaquim Pinheiro, Telmo Carvalho, et al.

    Background: The definition of significant stenosis (SS) remains controversial. Methods: We retrospectively reviewed 1,040 consultations. SS was defined in the presence of clinical and echo-Doppler (DDU) criteria: Qa 25%; RI >0.7 in the feeding artery or absolute minimal luminal stenosis diameter Results: Two hundred twenty-one arteriovenous fistulas (AVFs) were included: 58.8% had SS, 18.6% had BS, and 22.6% had no dysfunctional access (ND). SS had a significantly higher thrombotic events than BS and ND (13.1 vs. 4.4%, p = 0.018). The annual thrombosis rate was 0.007, 0.037, and 0.004 in the ND, SS, and BS, respectively. AVF cumulative survival at 5 years was significantly lower in SS (89.5%) compared to BS (100%) and ND (97.4%; p = 0.03). BS had an HR for AVF failure of 1.1, p = 0.955, while the SS presented an HR of 5.9, p = 0.09. Conclusion: AVF clinical monitoring with additional DDU criteria appear to be appropriate for therapeutic referral.


  • MP655COLOR DOPPLER ULTRASOUND ASSESSMENT OF JUXTA-ANASTOMOTIC STENOSIS IN RADIOCEPHALIC ARTERIOVENOUS FISTULAS: ENDOVASCULAR OR SURGICAL APPROACH

    by Ana Pimentel, Norton De Matos, Gabriela Teixeira, Joaquim Pinheiro, José Queirós, Paulo Almeida, Luís Loureiro, Duarte Rego, Isabel Fonseca, Telmo Carvalho

  • Does Pre- and Post-Angioplasty Doppler Ultrasound Evaluation Help in Predicting Vascular Access Outcome?

    by Maria Guedes-Marques, Pedro A. Maia, Fernando Neves, Aníbal Ferreira, João Cruz, Dulce Carvalho, Carlos Oliveira, Carlos Barreto, Telmo Carvalho, Pedro Ponce

    Background: Kidney Disease – Improving Global Outcomes (KDIGO) recommends post-percutaneous transluminal angioplasty (PTA) 2-fold ABF increase had no significant impact on fistulas (p>0.05) but was significantly associated with worst outcomes in grafts (23.1% vs. 73.5%, p 0.009). Grafts had lower survival (HR 3.3, p 0.034). Conclusions: Although less accurate for central lesions, DU has a key role on VA surveillance, allowing a morphologic and hemodynamic assessment. Angioplasty is effective in preserving VA; however, it may increase restenosis due to accelerated neointimal hyperplasia. Current parameters are not useful. Trials addressing this issue are needed.


  • Preoperative Vessel Mapping in Chronic Kidney Disease Patients - a Center Experience

    by Patrícia Barreto, Paulo Almeida, Norton de Matos, José Alexandre Queirós, Joaquim Pinheiro, Fernanda Silva, Telmo Carvalho, Rui Almeida, António Cabrita

    Purpose: Hemodialysis (HD) is the main treatment modality in stage 5 chronic kidney disease, and vascular access planning is a crucial step in the path to dialysis treatment. Beyond detailed patient history and physical examination, duplex ultrasound (DU) evaluation is essential in preoperative vascular mapping. Methods: A retrospective descriptive nonrandomized study was performed and included 108 end-stage kidney disease patients referred from eight HD centers to be assessed for creation of an arteriovenous (AV) access (AV fistula or AV graft). We assessed primary failure, primary unassisted patency (PP) and primary assisted patency (PAP) rates and cumulative survival of AV accesses at 6 and 12 months. Results: We created 86 AV accesses of which 79 (91.9%) were AV fistulas (AVFs) (29 distal AVFs, 49 proximal AVFs and 1 femorofemoral AVF) and 7 (8.1%) arteriovenous grafts (AVGs). Fifteen percent (15%) (n = 12) of primary failure occurred in the AVF group. Any case of primary failure was observed between AVGs. In the AVF group, PP at 6 months was 63.8% and at 12 months was 48.3%, PAP was 80.7% at 6 and 12 months. PP excluding primary failures was 73.0% and 55.3% at 6 and 12 months, respectively. The cumulative survival at 6 and 12 months was 80.7%. In the AVG group, PP at 6 months and 12 months was 66.7%, PAP and cumulative survival at 6 and 12 months were of 100%. Conclusions: This study demonstrates that preoperative vascular mapping with a patient-centered approach may be critical to achieve good outcomes allowing the increase in AVF access.


  • Assessing the Approach to a Thrombosed AV Graft

    by Pedro Ponce, Telmo Carvalho, Humberto Messias, Fernando Neves, the Lisbon VAC Interventional Nephrology Team

    The patency of the vascular access (VA) is a fight for the attending nephrologist. A retrospective observational study was conducted to compare the success rate of surgical versus endovascular technique percutaneous transluminal angioplasty (PTA) for graft thrombosis treatment. Of 3008 patients, 22.1% patients were dialyzed through grafts. Forty‐five percent of all prevalent patients referred due to VA malfunction had a graft. For 18 months, 336 thrombosed grafts were submitted to surgery in 228 cases and to PTA in 126. PTA for thrombolysis included the Pharmaco‐Mechanical Technique and the Arrow‐Trerotola Device. Procedures were performed as outpatient, with an average delay of 1 day. Immediate success was 100% for surgery and 87.3% for PTA. The unassisted patency for thrombosed grafts for surgery/PTAwas 265.12 ± 15.30/230.59 ± 19.83 days respectively, favoring surgery. The primary patency for thrombosed grafts treated by surgery/PTA at 30, 90, and 180 days was, respectively, 74.1%/81%, 63.2%/67.5%, and 53.9%/55.6% all in favor of PTA. AV grafts have a much higher rate of thrombosis than fistulas. Graft thrombosis can be dealt either by surgery or PTA, with identical success.


  • Efficacy of preventing hemodialysis catheter infections with citrate lock

    by Jorge Silva, Jorge Antunes, Telmo Carvalho, Pedro Ponce

    Prevalent use of tunneled dialysis catheters can reach 30%. Infection remains the most serious catheter‐related problem. Catheter locks are increasingly used for prevention, but are not yet recommended either by the Food and Drug Association or European Medicines Agency, on the basis of increasing bacterial resistance or lock toxicity. The aim was to test safety and effectiveness of citrate. A prospective, interventional study was conducted to assess the safety and efficacy of a 30% citrate lock in preventing catheter‐related bacteremia (CRB). A total of 157 prevalent tunneled catheters were locked with citrate and prospectively followed during a 1‐year period. The primary endpoint was first CRB diagnosed according to two of the diagnostic criteria for Catheter Infection of Centers for Disease Control and Prevention (CDC), namely definite and probable infection. The CDC criterion of possible but not proved infection was not considered. This citrate lock cohort (n = 157) had 10 episodes of CRB. We observed 0.49 CRB episodes/1000 patient‐days and the mean infection‐free catheter day was 130.6 ± 100.9. No clinically relevant adverse events were observed. No proved tunnel or exit site infection was observed and no patients died because of CRB. Catheter obstruction episodes were reported on 69 occasions out of 14 catheters. These results were compared with an historical cohort from a previous study of catheter locking with low‐dose gentamicin and did not show significant difference in efficacy. Citrate lock is effective in preventing CRB. No toxicity was observed. The use of citrate lock may have advantages over antibiotic locks: No reported bacterial resistance, lower industrial cost, and less manipulation.